CRISPR/Cas9-mediated targeted chromosome elimination

Erwei Zuo(Chinese Academy of Sciences), Xiaona Huo(Chinese Academy of Sciences), Xuan Yao(Chinese Academy of Sciences), Xinde Hu(Chinese Academy of Sciences), Yidi Sun(Chinese Academy of Sciences), Jianhang Yin(Peking University), Bingbing He(Chinese Academy of Sciences), Xing Wang(Chinese Academy of Sciences), Linyu Shi(Chinese Academy of Sciences), Jie Ping(Vanderbilt University), Wei Yu(Shanghai University), Wenqin Ying(Chinese Academy of Sciences), Wei Wei(Shanghai University), Wenjia Liu(Chinese Academy of Sciences), Cheng Tang(Chinese Academy of Sciences), Yixue Li(Chinese Academy of Sciences), Jiazhi Hu(Peking University), Hui Yang(Chinese Academy of Sciences)
Genome biology
November 24, 2017
Cited by 196Open Access
Full Text

Abstract

BACKGROUND: The CRISPR/Cas9 system has become an efficient gene editing method for generating cells carrying precise gene mutations, including the rearrangement and deletion of chromosomal segments. However, whether an entire chromosome could be eliminated by this technology is still unknown. RESULTS: Here we demonstrate the use of the CRISPR/Cas9 system to eliminate targeted chromosomes. Using either multiple cleavages induced by a single-guide RNA (sgRNA) that targets multiple chromosome-specific sites or a cocktail of multiple sgRNAs, each targeting one specific site, we found that a sex chromosome could be selectively eliminated in cultured cells, embryos, and tissues in vivo. Furthermore, this approach was able to produce a targeted autosome loss in aneuploid mouse embryonic stem cells with an extra human chromosome and human induced pluripotent stem cells with trisomy 21, as well as cancer cells. CONCLUSIONS: CRISPR/Cas9-mediated targeted chromosome elimination offers a new approach to develop animal models with chromosome deletions, and a potential therapeutic strategy for human aneuploidy diseases involving additional chromosomes.


Related Papers

No related papers found

Powered by citation graph analysis